Tango Therapeutics Inc
|Market Cap (Intraday)||1.09B|
|2yr Forward PE||N/A|
Tango Therapeutics Inc Stock, NASDAQ:TNGX
Tango Therapeutics, Inc. operates as a biotechnology company that engages in discovering and delivering precision cancer medicines. The company was founded by Alan Ashworth, William G. Kaelin, Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Cambridge, MA.